Literature DB >> 11819449

Bioartificial liver support for fulminant hepatic failure.

Robert S Brown, Howard J Worman.   

Abstract

Entities:  

Year:  1999        PMID： 11819449      PMCID： PMC4695536          DOI： 10.3748/wjg.v5.i4.286

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  11 in total

1.  Bone marrow as a potential source of hepatic oval cells.

Authors:  B E Petersen; W C Bowen; K D Patrene; W M Mars; A K Sullivan; N Murase; S S Boggs; J S Greenberger; J P Goff
Journal:  Science       Date:  1999-05-14       Impact factor: 47.728

2.  Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.

Authors:  A J Ellis; R D Hughes; J A Wendon; J Dunne; P G Langley; J H Kelly; G T Gislason; N L Sussman; R Williams
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

3.  Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.

Authors:  F D Watanabe; C J Mullon; W R Hewitt; N Arkadopoulos; E Kahaku; S Eguchi; T Khalili; W Arnaout; C R Shackleton; J Rozga; B Solomon; A A Demetriou
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

4.  Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage.

Authors:  L F Prescott; P Roscoe; N Wright; S S Brown
Journal:  Lancet       Date:  1971-03-13       Impact factor: 79.321

Review 5.  Fulminant and subfulminant liver failure: definitions and causes.

Authors:  J Bernuau; B Rueff; J P Benhamou
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

6.  Effects of a bioartificial liver support system on acetaminophen induced acute liver failure canines.

Authors:  Yi-Long Xue; Shi-Feng Zhao; Zuo-Yun Zhang; Yue-Feng Wang; Xin-Jian Li; Xiao-Qiang Huang; Yun Luo; Ying-Cai Huang; Cheng-Gui Liu
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

7.  Ischemic hepatitis: widening horizons.

Authors:  N Gitlin; K M Serio
Journal:  Am J Gastroenterol       Date:  1992-07       Impact factor: 10.864

8.  The Hepatix extracorporeal liver assist device: initial clinical experience.

Authors:  N L Sussman; G T Gislason; C A Conlin; J H Kelly
Journal:  Artif Organs       Date:  1994-05       Impact factor: 3.094

9.  Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.

Authors:  S L Nyberg; R P Remmel; H J Mann; M V Peshwa; W S Hu; F B Cerra
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

Review 10.  Extracorporeal liver support. Application to fulminant hepatic failure.

Authors:  N L Sussman; G T Gislason; J H Kelly
Journal:  J Clin Gastroenterol       Date:  1994-06       Impact factor: 3.062
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.